The Geneva Biotech Center

Providing quality investment opportunities in pharmaceutical Research & Development

GBC moves to Innovation Center

June 1st, 2016 The Geneva Biotech Center (GBC-SA) announces the move of its headquarters from its previous address at 14, Chemin des Aulx in Plan-les-Ouates, Switzerland to its new premises at the Innovation Park of the Biotech Campus at 15, Avenue de S├ęcheron, 1202 Geneva, Switzerland.

Latest news

GBC moves to Innovation Center

June 1st, 2016 The Geneva Biotech Center (GBC-SA) announces the move of its headquarters from its previous address at 14, Chemin des Aulx in Plan-les-Ouates, Switzerland to its new premises at the Innovation Park of the Biotech Campus at 15, ...

GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich

Geneva, Switzerland, May 3rd, 2016. The GBC has obtained the exclusive worldwide rights to a molecule discovered at the University of Zurich, and which is expected to have a high potential to treat allergic and chronic inflammatory diseases. The ...

new CMO

The GBC appoints new Chief Medical Officer Geneva, Switzerland, September 1st, 2015. The Geneva Biotech Center (GBC-SA) announces the appointment of Christine Serratrice, MD, as Chief Medical Officer. In this role, Dr. Serratrice will play a ...

GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd.

GBC-Atrial SA licenses Worldwide Rights to a Cardiovascular Compound with Potential to Treat Cardiac Rhythm Related Disorders Geneva, Switzerland, May 5th, 2015. GBC-Atrial SA, an affiliate of the Geneva Biotechnology Company (GBC) SA, ...

CONTACT US

If you would like more information on our quality investment opportunities or on-going projects, please contact us!

Go Top